Skip to main content
. 2018 May 31;20(Suppl F):F1–F74. doi: 10.1093/eurheartj/suy019

Figure 36.

Figure 36

Cardiovascular death, myocardial infarction (MI) or stroke in randomised placebo patients at 90 days and at three years from the moment of interruption of the P2Y12 receptor inhibitor.

CV, cardiovascular; HR, hazard ratio; CI, confidence interval; AMI, acute myocardial infarction.

Modified by Bonaca et al.146